INS and diabetes mellitus: Diabetes mellitus (DM) may be a cofactor in AD progression due to selective impairment in insulin production, metabolism, or signaling, accompanied by significant upregulation of tau hyperphosphorylation, β-amyloid aggregation, inflammation, mitochondrial dysfunction, and oxidative stress.